DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $485,256 | +91.1% | 54,158 | +140.0% | 0.00% | – |
| Q2 2023 | $253,901 | +1421.1% | 22,569 | +1457.6% | 0.00% | – |
| Q1 2023 | $16,692 | -85.0% | 1,449 | -84.9% | 0.00% | – |
| Q4 2022 | $110,986 | +753.7% | 9,576 | +815.5% | 0.00% | – |
| Q3 2022 | $13,000 | +85.7% | 1,046 | +1.6% | 0.00% | – |
| Q2 2022 | $7,000 | -92.9% | 1,030 | -89.9% | 0.00% | – |
| Q1 2022 | $98,000 | +1860.0% | 10,172 | +2368.9% | 0.00% | – |
| Q4 2021 | $5,000 | – | 412 | +1548.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 25 | -99.2% | 0.00% | – |
| Q1 2021 | $51,000 | -75.6% | 3,278 | -67.1% | 0.00% | – |
| Q4 2020 | $209,000 | – | 9,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |